Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
1(100.0%)
1Total
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00633854Completed

High-frequency-ultrasound Annular Arrays for Ophthalmic Imaging

Role: collaborator

NCT01415037Completed

Annular Array Ultrasound in Ophthalmology

Role: collaborator

NCT01227642Phase 1Completed

Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate Brachytherapy

Role: collaborator

NCT00279695Unknown

Ultrasonic Evaluation of Ocular Tissues

Role: collaborator

All 4 trials loaded